^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    TQ-B3234

    i
    Other names: TQ-B3234
    Associations

    News

    Trials
    Company:
    Sino Biopharm
    Drug class:
    MEK1 inhibitor, MEK2 inhibitor
    Related drugs:
    Associations

    News

    Trials
    1d
    Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas (clinicaltrials.gov)
    P3, N=177, Recruiting, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Not yet recruiting --> Recruiting
    Enrollment open
    |
    NF1 (Neurofibromin 1)
    |
    TQ-B3234
    2ms
    Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas (clinicaltrials.gov)
    P3, N=177, Not yet recruiting, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
    New P3 trial
    |
    NF1 (Neurofibromin 1)
    |
    TQ-B3234
    over4years
    A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of TQ-B3234 in Patients With Type I Neurofibromatosis (clinicaltrials.gov)
    P1, N=120, Not yet recruiting, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
    Clinical • New P1 trial
    |
    NF1 (Neurofibromin 1)
    |
    NF1 mutation
    |
    TQ-B3234